SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-041625
Filing Date
2021-02-12
Accepted
2021-02-12 16:25:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d78081dsc13g.htm SC 13G 36438
  Complete submission text file 0001193125-21-041625.txt   37900
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Subject) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88050 | Film No.: 21627992
SIC: 2834 Pharmaceutical Preparations

Mailing Address 360-1616 EASTLAKE AVENUE E. SEATTLE WA 98102
Business Address
Silva Manzano Daniel Adriano (Filed by) CIK: 0001803051 (see all company filings)

Type: SC 13G